J&J Seeks EUA for COVID-19 Vaccine
Current advances in the development of SARS-CoV-2 vaccines
Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen's Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19
Johnson & Johnson 'Pauses' COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment - Health Policy Watch
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Advances in gene-based vaccine platforms to address the COVID-19 pandemic - ScienceDirect
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines
.png "Comparing COVID-19 Vaccines - ChemistryViews")
Comparing COVID-19 Vaccines - ChemistryViews
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
Vaccines for COVID‐19 - Tregoning - 2020 - Clinical & Experimental Immunology - Wiley Online Library
What Providers Need To Know About Janssen COVID-19 Vaccine (Johnson & Johnson)
University of Chicago Medicine begins recruiting participants for phase 3 COVID-19 investigational vaccine clinical trial - UChicago Medicine
Maintaining Safety with SARS-CoV-2 Vaccines | NEJM
Frontiers | The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
What is a Mosaic HIV Vaccine and How Does it Work? | Johnson & Johnson
Developing COVID-19 Vaccines in Record Time NAIIS – 5/12/2020 1
J&J's COVID-19 Vaccine Generates Antibodies in Primates, Preclinical Data Shows | BioSpace
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
